Please login first
A possible anti-inflammatory capacity of chlorogenic acid
* 1 , * 2 , 3 , 4
1  Dentist by Universidade Federal de Pelotas, Pelotas (Rio Grande do Sul), Brasil
2  Doctor in Physiological Sciences by Universidade Federal do Rio Grande - FURG, Rio Grande (Rio Grande do Sul), Brasil
3  Doctor in Health Sciences by Universidade Federal do Rio Grande - FURG, Professor at Instituto-Federal-Sul-Riograndense, Jaguarão (Rio Grande do Sul), Brasil
4  Doctor in Chemistry by Universidade Federal do Rio Grande do Sul – UFRGS, Professor at Universidade Federal do Pampa, Bagé (Rio Grande do Sul), Brasil

https://doi.org/10.3390/mol2net-06-06941 (registering DOI)
Abstract:

Inflammatory processes, although important for tissue homeostasis, can suffer imbalances and be related to several diseases. An important enzyme involved in the mediation of inflammatory processes is cyclooxygenase 2 (COX-2), which generates prostaglandins from arachidonic acid. In this context, this enzyme is an important drug target and its inhibition is a mechanism present in several anti-inflammatory drugs. The chlorogenic acid (CHLORO) could act in an inhibitory way on COX-2 and there are reports of anti-inflammatory actions of this molecule. To evaluate the possible inhibitory power on COX-2 of chlorogenic acid through molecular docking was the objective of this study. The docking simulation by AutoDock Vina demonstrated a binding energy with the COX-2 of -9.5 Kcal/mol. Besides that, COX-2 and CHLORO stablished 09 Hydrogen bonds and 06 hydrophobic interactions. The binding energy and types of binding established with COX-2 can demonstrate the anti-inflammatory properties of the CHLORO. In this sense, it would be important to continue in vitro and in vivo studies.

Keywords: Prostaglandins; Docking; Binding energy.
Comments on this paper
Rajeev K Singla
Excellent Study
The in silico experimentation to prove the COX-2 inhibitory effect of chlorgenic acid was meticulously performed. This will aid in the drug discovery, for designing selective and specific COX-2 inhibitor.



 
 
Top